Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Longeveron Inc LGVN

Healthcare Biotechnology
Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LGVN)

Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 9 days ago

Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)

GlobeNewswire 10 days ago

Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

GlobeNewswire November 4, 2024

Longeveron® Presents Lomecel-B(TM) Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)

GlobeNewswire October 29, 2024

Longeveron® Presents Lomecel-B(TM) Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting

GlobeNewswire October 27, 2024

Longeveron® Lomecel-B(TM) Data in Alzheimer's Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)

GlobeNewswire October 14, 2024

Longeveron® Lomecel-B(TM) 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting

GlobeNewswire October 9, 2024

Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day

GlobeNewswire October 7, 2024

Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GlobeNewswire October 2, 2024
View More News ››

Opinion & Analysis (NDAQ:LGVN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LGVN)

Longeveron&#xAE; to Report Third Quarter 2024 Financial Resu

Just In: $LGVN Longeveron&#xAE; to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024MIAMI...
whytestocks - November 4, 2024

Longeveron&#xAE; Presents Lomecel-B(TM)&#xA0;Data for Alzhei

NEWS: $LGVN Longeveron&#xAE; Presents Lomecel-B(TM)&#xA0;Data for Alzheimer's Disease Indication in Late Breaking Poster...
whytestocks - October 29, 2024

InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) to Parti

JUST IN: $LGVN InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) to Participate at the Cell & Gene Meeting on the MesaLongeveron...
whytestocks - September 26, 2024

InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) Schedule

NEWS: $LGVN InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) Schedules Release of Q2 2024 Financial Results, Earnings Conference...
whytestocks - August 6, 2024

LGVN....Nr on P.O

done
Iseneschal - July 18, 2024

Longeveron&#xAE; Announces U.S. FDA Grants Fast Track Design

News; $LGVN Longeveron&#xAE; Announces U.S. FDA Grants Fast Track Designation for Lomecel-B(TM) for the Treatment of Mild Alzheimer&...
whytestocks - July 17, 2024
View more Bullboard ››

Kootenay Silver Inc.

Kootenay Silver Inc.

Kootenay Silver Inc. is a Canada-based exploration company engaged in the discovery and development of mineral projects in ...
View More »